Petmed Express Stock Today
| PETS Stock | USD 4.04 0.04 1.00% |
PerformanceVery Weak
| Odds Of DistressLow
|
PetMed Express is selling for under 4.04 as of the 19th of March 2025; that is 1.00 percent increase since the beginning of the trading day. The stock's lowest day price was 3.92. PetMed Express has only a 8 % chance of going through financial distress over the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 19th of December 2024 and ending today, the 19th of March 2025. Click here to learn more.
Business Domain Consumer Discretionary Distribution & Retail | IPO Date 26th of April 1999 | Category Healthcare | Classification Consumer Discretionary |
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida. Petmed Express operates under Pharmaceutical Retailers classification in the United States and is traded on NASDAQ Exchange. The company has 20.66 M outstanding shares of which 1.5 M shares are at this time shorted by private and institutional investors with about 5.15 trading days to cover. More on PetMed Express
Moving together with PetMed Stock
Moving against PetMed Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
PetMed Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO President | Sandra Campos | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Ideas | (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Other Specialty Retail, Consumer Discretionary Distribution & Retail, Consumer Discretionary, NASDAQ Composite, NASDAQ Composite Total, Marketing, Trump Equities, Consumer Discretionary, Specialty Retail, Pharmaceutical Retailers, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsPetMed Express can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand PetMed Express' financial leverage. It provides some insight into what part of PetMed Express' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
PetMed Express (PETS) is traded on NASDAQ Exchange in USA. It is located in 420 South Congress Avenue, Delray Beach, FL, United States, 33445 and employs 287 people. PetMed Express is listed under Other Specialty Retail category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 82.63 M. PetMed Express conducts business under Specialty Retail sector and is part of Consumer Discretionary industry. The entity has 20.66 M outstanding shares of which 1.5 M shares are at this time shorted by private and institutional investors with about 5.15 trading days to cover.
PetMed Express currently holds about 105.41 M in cash with 4.32 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.21, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check PetMed Express Probability Of Bankruptcy
Ownership AllocationPetMed Express owns a total of 20.66 Million outstanding shares. PetMed Express has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check PetMed Ownership Details
PetMed Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| D. E. Shaw & Co Lp | 2024-12-31 | 172 K | |
| Ubs Group Ag | 2024-12-31 | 150.8 K | |
| Amvescap Plc. | 2024-12-31 | 148.8 K | |
| Invenomic Capital Management, Lp | 2024-12-31 | 148.4 K | |
| Ameriprise Financial Inc | 2024-12-31 | 146.4 K | |
| Man Group Plc | 2024-12-31 | 145.8 K | |
| Millennium Management Llc | 2024-12-31 | 144.1 K | |
| Formidable Asset Management Llc | 135.3 K | ||
| T. Rowe Price Associates, Inc. | 2024-12-31 | 121.7 K | |
| Renaissance Technologies Corp | 2024-12-31 | 1.3 M | |
| Hotchkis & Wiley Capital Management Llc | 2024-12-31 | 974.1 K |
PetMed Express Historical Income Statement
PetMed Stock Against Markets
PetMed Express Corporate Management
| Mark Moseley | Chief Officer | Profile | |
| Carla Dodds | Chief Officer | Profile | |
| Matthew Hulett | Pres CEO | Profile | |
| Umesh Sripad | Chief Officer | Profile | |
| Christine Chambers | Treasurer Secretary | Profile |
Additional Tools for PetMed Stock Analysis
When running PetMed Express' price analysis, check to measure PetMed Express' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PetMed Express is operating at the current time. Most of PetMed Express' value examination focuses on studying past and present price action to predict the probability of PetMed Express' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PetMed Express' price. Additionally, you may evaluate how the addition of PetMed Express to your portfolios can decrease your overall portfolio volatility.